Does it Matter Whether Canada’s Separate Health Technology...

PharmacoEconomics 2015 / 8 Vol. 33; Iss. 8

Does it Matter Whether Canada’s Separate Health Technology Assessment Process for Cancer Drugs has an Economic Rationale?

Hoch, Jeffrey S., Beca, Jaclyn, Sabharwal, Mona, Livingstone, Scott W., Fields, Anthony L. A.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
33
Language:
english
Journal:
PharmacoEconomics
DOI:
10.1007/s40273-015-0278-7
Date:
August, 2015
File:
PDF, 453 KB
english, 2015
Conversion to is in progress
Conversion to is failed